PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
August 18, 2024Open Access

What is the impact of the 340B program on drug access, healthcare quality, and finances among low-income and/or uninsured patients?

View Full Paper
Ask AI
Bookmark
Share

Authors

AGAneesh GangireddyJAJohn Anagnost

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gangireddy et al. (2024) studied this question.

synapsesocial.com/papers/68e5bd40b6db6435875554e3https://doi.org/10.58445/rars.1492
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of 340B drug pricing program on specialty medication access: A policy analysis and future directions2024
  2. 2Reforming 340B to Promote Program Integrity and Better Serve Vulnerable Populations: An American College of Physicians Policy Brief2026
  3. 3Stretching Scarce Authorizing Legislation as Far as Possible: A Legislative History of the 340B Drug Pricing Program2026
  4. 4US Hospital Service Availability and New 340B Program Participation2024 · 16 citations
  5. 5Association of 340B entity eligibility with changes in hospital financial performance2026